Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism 5-HT2C receptor agonists(Serotonin 2c (5-HT2c) receptor agonists), TAAR1 agonists(Trace amine-associated receptor 1 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Phase 1 | - | 01 Aug 2024 | |
Schizophrenia | Phase 1 | - | 01 Aug 2024 |